Engineering Human Biology with Bioinspired Innovation - Prof. Donald E. Ingber
Prof. Donald E. Ingber to Deliver Plenary Session(In-Person) at InnoPharm-2026
InnoPharm-2026 is proud to announce Prof. Donald E. Ingber, Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, as a distinguished Plenary Speaker at this year’s conference.
A visionary scientist working at the convergence of biology, engineering, and medicine, Prof. Ingber has played a transformative role in redefining how human physiology is studied and translated into therapeutic innovation. His pioneering work in organ-on-chip technology has introduced microengineered systems that replicate the structure and function of living human organs, offering unprecedented opportunities to model disease and evaluate drug responses with remarkable accuracy.
Over the past decades, his contributions to mechanobiology-the study of how physical forces influence cellular behavior-have provided deep insights into disease mechanisms ranging from cancer progression to organ dysfunction. By integrating engineering principles with biological systems, his research has helped bridge longstanding gaps between laboratory discovery and clinical application.
Why It Matters:
As the pharmaceutical industry faces increasing pressure to improve efficiency and reduce late-stage failures, Prof. Ingber’s innovations provide a powerful alternative to traditional preclinical models. His work enables more predictive, human-relevant testing platforms that can accelerate drug development timelines, enhance safety assessment, and reduce dependence on animal studies. These advances are particularly critical in the era of precision medicine, where accurate modeling of human biology is essential.
About Prof. Ingber:
- Founding Director, Wyss Institute for Biologically Inspired Engineering, Harvard University
- Professor at Harvard Medical School and Harvard School of Engineering and Applied Sciences
- Pioneer in organ-on-chip technology and mechanobiology
- Member of the National Academy of Medicine, National Academy of Engineering, and American Academy of Arts and Sciences
- Founder of multiple biotechnology companies translating academic research into real-world applications